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1. Introduction 
Text Osteoarthritis (OA) is the most common musculoskeletal disease in developed 
countries. It is characterized by progressive degradation of articular cartilage that leads to 
joint space narrowing, subchondral sclerosis, osteophyte and cyst formation, and eventually 
loss of joint function. While OA can be secondary to various factors, the majority of cases are 
considered primary. Certain OA forms have long been known to have a genetic component. 
Based on twin studies the heritability of OA has been estimated to be around 50 %. Since the 
disease is complex, with environmental and genetic factors acting together, the knowledge 
of the etiology and development of preventive medication have been a challenge. A better 
understanding of the predisposing genes and biological mechanisms behind OA are 
essential for future drug development. 
The current estimate of the number of genes in the human genome is 23 500  (Patterson 
2011). Almost the entire genome of 3.2 x 109 base pairs is identical between any two 
individuals, excluding the 0.1 % that varies. A large fraction of the variation is common in 
the general population, i.e. the variant allele is seen as often or almost as often as the wild-
type allele. However, some of the variation is rare, seen only in less than 1% of individuals 
or possibly even unique to one person. The early genetic studies were performed by 
selecting biologically interesting candidate genes and searching for sequence variants 
segregating with the disease in families with multiple affected individuals or variants 
identified from a small number of affected cases. Many of these studies concentrated on 
genes coding for the structural components of cartilage, like the collagens (for reviews, see 
(Kuivaniemi et al. 1997; Loughlin 2001)). 
Next, genome-wide studies were launched to search for chromosomal regions co-
segregating with a disease in families or in sibling pairs. The genome-wide linkage 
analyses utilized a set of variants throughout the genome without prior knowledge or 
hypothesis of the function of the genes. Initially a few hundred microsatellite markers, 
which were located on average 10 million base pairs apart, were selected throughout the 
human genome. The chromosomal regions identified by the linkage analysis were usually 
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very large, containing hundreds of genes, and needed fine mapping with additional 
genetic markers to better locate the genome region of interest. The genome-wide linkage 
study approach has been very successful in locating disease-causing genes for monogenic 
diseases (for example (Kestilä et al. 1994; Mäkelä-Bengs et al. 1998; Nousiainen et al. 
2008)). Genes causing rare, familial forms of OA have been identified by genetic linkage 
studies, which have also revealed novel insight on OA etiology, even though the 
identified variants have not been significant in predisposing to common forms of OA at 
the population level (Palotie et al. 1989; Ala-Kokko et al. 1990; Vikkula et al. 1993; Prockop 
et al. 1997; Jakkula et al. 2005). 
In recent years, the knowledge of the human genome has grown substantially. The linkage 
disequilibrium (LD) structure of the human genome was studied in the international 
HapMap project, gaining understanding of genetic tag markers that are informative and can 
cover surrounding regions of the genome (Gibbs et al. 2003). That and the technological 
improvements in genotyping methods have decreased the cost of genotyping and thus 
enabled high throughput gene mapping studies with large numbers of informative variants 
in a large number samples (Craddock et al. 2010; Lango Allen et al. 2010). Genome-wide 
association studies use hundreds of thousands of tag markers throughout the genome and 
require no priori hypothesis on the disease etiology. The association is measured by a 
statistical test of the co-occurrence of an allele with a phenotype. The basic research frame in 
an association study is a case-control sample set of unrelated individuals. Genome-wide 
association analysis (GWAS) is usually performed with common single nucleotide 
polymorphism (SNP) markers. GWAS aiming to identify predisposing variants for common, 
multifactorial diseases require large sample sizes because the effect of a single variant is 
typically small. So far, GWAS studies of OA phenotypes have revealed few confirmed 
variants. 
Many of the initial genetic associations have not been replicated in the follow-up studies. 
This may be due to many different factors such as a false positive original finding, a small 
sample size in the replication study, which does not have the power to detect a true 
association with a small effect size, or a difference in phenotypes between studies. An 
accurately defined phenotype should be reliably measurable and represent the biological 
phenomenon as closely as possible. Sometimes the optimal phenotyping method for a 
genetic study does not correspond with the diagnostic criteria used in patient care. For 
example, pain is an important symptom in evaluating the need for treatment in OA, but it is 
typically a poor phenotype for genetic studies since it can be caused by several factors and it 
is difficult to measure reliably. 
Our aim is to review the studies aiming to identify disease-predisposing variants for 
different OA phenotypes. We will summarize different genome-wide linkage (GWL) and 
some of the earlier candidate gene studies performed in OA. Additionally we will present 
the novel findings in recent genome-wide association studies and discuss the challenges 
confronted in gene mapping studies of complex disease.  
2. Heritability 
Heritability is defined as the proportion of the total phenotypic variation that is caused by 
genetic factors. The heritability can vary between 1 - 100 % and it is dependent on the 
studied population. For example, the heritability of height is roughly 80 % (Silventoinen et 
al. 2003). Traditionally, twins have been used as study subjects for heritability estimates; 
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monozygotic twins share 100 % of their genome and dizygotic twins share on average 50 % 
of their genome. Since twins share their prenatal environment and often most of the 
environmental factors later in life, the higher concordance in the phenotype between 
monozygotic twins than between dizygotic twins is considered to be caused by genetic 
factors (Kempthorne et al. 1961). 
In OA the heritability estimates have also varied between the study populations and 
different OA types, but can roughly be estimated to be between 50-60 %. Based on a twin 
study by Page et al. (2003), the heritability of hip OA was approximately more than half in 
males in the USA; the genetic effect on self-reported hip replacement surgery was 53 % and 
the effect for radiologically verified primary hip OA was 61%. Similar results were observed 
in a study by MacGregor et al. (2000) with a UK population-based cohort of women: 
Heritability of 58% was observed for radiographic hip OA and 64% for radiographic joint 
space narrowing. High heritability estimates were reported for radiological knee OA of 
medial osteophytes (69 %) and for joint space narrowing (80%) in a population-based study 
with twins from the UK (Zhai et al. 2007). The heritability of radiographic hand OA has been 
shown to vary between 47.6 % and 67.4 % in an UK population-based study sample of 
females. The lower value was for DIP OA based on joint space narrowing and osteophytes, 
and the upper value the total Kellgren and Lawrence value for all 30 hand joints (Livshits et 
al. 2007).  
3. Genome-wide linkage studies 
Similarly as in other complex diseases the early genetic studies in OA focused on rare 
families and genes known to have a biological role in the development and structure of 
cartilage (Palotie et al. 1989; Ala-Kokko et al. 1990; Vikkula et al. 1993; Jakkula et al. 2005). In 
the 1990s, the introduction of panels of highly informative microsatellite markers evenly 
covering the genome allowed hypothesis-free screening with no prior knowledge of the 
gene functions (Petrukhin et al. 1993; Straub et al. 1993). 
The first genome-wide linkage studies in OA families were published over ten years ago 
(Leppävuori et al. 1999; Loughlin et al. 1999). They were followed by a number of twin, sib 
pair, and family-based studies and their meta-analysis, which together have identified at least 
fifteen OA loci with a genome-wide significant logarithm of odds score (LOD  ≥ 3.3) 
(Leppävuori et al. 1999; Loughlin et al. 1999; Ingvarsson et al. 2001; Demissie et al. 2002; 
Loughlin et al. 2002b; Stefansson et al. 2003; Forster et al. 2004b; Hunter et al. 2004; Loughlin et 
al. 2004; Southam et al. 2004; Greig et al. 2006; Lee et al. 2006; Mabuchi et al. 2006; Meulenbelt 
et al. 2006; Livshits et al. 2007; Min et al. 2007; Meulenbelt et al. 2008). Of these, loci in 2p23-
p24, 2q31-q33, 4q31-q32, 7q34-q36, and 19q13 have been implicated also in other independent 
studies. Table 1 lists loci identified with genome-wide significant evidence for linkage at least 
in one study and also additional studies showing suggestive evidence for linkage for these 
loci. However, since the identified linkage peaks have typically been wide and the marker 
maps quite sparse, it is challenging to evaluate the true overlap between the studies.   
Although the linkage screens and their follow-up fine mapping studies have revealed 
several interesting OA candidate loci, very few, if any, OA predisposing variants that 
would explain the observed linkage have been identified within these loci. Loci with 
genome-wide significant evidence for linkage supported by at least one independent 
study, as well as some of the candidate genes within these regions, are shortly described 
below. 
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Chr LOD Phenotype Country
n (individuals in 
screening/finemapping) 
n (families or sibpairs)** 
Ref. 
2p23.3–24.1 4.4 DIP/CMC1 Iceland 
1143 cases + 939 relatives / 2162 
cases + 873 controls 
329 families (≥2 aff/fam) 
(Stefansson 
et al. 2003) 
2p23.3 2.2 JSN, hand USA 
1477 / -
296 families 
(Demissie 
et al. 2002) 
2p13.2–2p14 
and 
2p12–13.3 
2.9 
and 
4.0 
DIP
and 
Tot-KL, 
hand 
UK 
1028 / - 
DZ twins 
(Livshits  
et al. 2007) 
2q12-2q21 2.3 DIP Finland 
54
27 sib pairs 
(Leppävuori 
et al. 1999) 
2q31.1 1.6 Thumb IP USA 
1214 / -
267 families 
(Hunter  
et al. 2004) 
2q24.3–31.1 1.6 Hip UK 
Finemapping
> 962 / > 756 
481 families (≥2 aff sib pair /fam) 
/ 378 families (≥2 aff sib pair/fam) 
(Loughlin 
et al. 2000) 
(Loughlin 
et al. 2002b) 
2q32.1-2q34 
p=0.03 
meta 
Knee, hip, 
hand 
European
+ 
USA 
3000 
893 families 
(Lee et al. 
2006) 
2q23 2.2 CMC1 Iceland 
558
204 families 
(Stefansson 
et al. 2003) 
2q33.3 6.1 GOA 
Netherla
nds 
38 / 52+X
4/7 families 
1228 assoc 
(Meulenbelt 
et al. 2006) 
4q12–21.2 3.1 
Hip 
(women) 
UK 
178 female hip OA
85 families 
(Loughlin 
et al. 1999) 
4q13.1 2.7 
PIIANP 
biomarker 
Afr.Am/
Nat.Am. 
350
1 extended family 
(Chen  
et al. 2010) * 
4q13.3 3.1 
Hip 
(women) 
UK 
> 436
218 families (of which 146 THR) 
(Forster et 
al. 2004b)  
4q 2.3 DIP Finland 
54 
27 sibpairs 
(Leppävuo
ri et al. 
1999) 
4q31.3 3.3 DIP Iceland 
1143 cases + 939 relatives / 2162 
cases + 873 controls 
329 families (≥2 aff/fam) 
(Stefansson 
et al. 2003) 
4q32.3 3.8 
Tot-KL, 
hand 
UK 
1028 / -
DZ twins 
(Livshits et 
al. 2007) 
6p21.1–
q22.1 
2.1 Hip UK 
416
194 families 
(Loughlin 
et al. 1999) 
6p21.1-q15 
p=0.02 
meta 
Knee, hip, 
hand 
European
+ 
USA 
3000 
893 families 
(Lee  
et al. 2006) E 
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Chr LOD Phenotype Country
n (individuals in 
screening/finemapping) 
n (families or sibpairs)** 
Ref. 
6p11.1 4.8 
Hip 
(women) 
UK 
Finemapping 
> 292 
146 families 
(Southam 
et al. 2004) 
6p12 4.6 THR, hip UK 
> 756 
378 families (≥2 aff sib pair/fam) 
(Loughlin  
et al. 2002c) 
6q11.2–12 3.1 
Tot-KL, 
hand 
UK 
1028 / - 
DZ twins 
(Livshits  
et al. 2007) 
7q34-36 
p=0.004
meta 
Knee, hip, 
hand 
European
+ 
USA 
3000 
893 families 
(Lee et al. 
2006) 
7q32 1.1 Knee, hip UK 
641 
481 families 
(Chapman 
et al. 1999) 
7q35 3.1 DIP USA 
1214 / - 
267 families 
(Hunter et 
al. 2004) 
8p23.2 4.3 
PIIANP 
biomarker 
Afr.Am/
Nat.Am..
350 
1 extended family 
(Chen et 
al. 2010)* 
8p12 2.6 JSN, hand UK 
354 
128 families 
Greig et al. 
2006 
8q11 3.2 
COMP 
biomarker 
Afr.Am/
Nat.Am 
350 
1 extended family 
(Chen et 
al. 2010)* 
8q12–21 2.1 DIP USA 
1214 / - 
267 families 
(Hunter  
et al. 2004) 
8q24.2 2.5 COMP 
Afr.Am/
Nat.Am 
350 
1 extended family 
(Chen  
et al. 2010)* 
9q21.2 2.3 JSN, hand USA 
1477 / - 
296 families 
(Demissie 
et al. 2002) 
9q34.2–34.3 4.5 DIP UK 
1028 / - 
DZ twins 
(Livshits et 
al. 2007) 
11p12–
11q13.4 
p=0.02 
meta 
Knee, hip, 
hand 
European
+ 
USA 
3000 
893 families 
(Lee et al. 
2006) 
11p11 1.32 
Female 
knee, hip 
UK 
594 / 392 females 
294 families / 192 pairs 
 
(Chapman 
et al. 1999) 
12q21.3–22 3.9 DIP UK 
1028 / - 
DZ twins 
(Livshits  
et al. 2007) 
12q24.3 1.7 JSN, hand USA 
1477 / - 
296 families 
(Demissie 
et al. 2002) 
12q24.3 1.8 DIP USA 
1214 / - 
267 families 
(Hunter  
et al. 2004) 
13q 2.3 First CMC USA 
1214 / - 
267 families 
(Hunter  
et al. 2004) 
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Chr LOD Phenotype Country
n (individuals in 
screening/finemapping) 
n (families or sibpairs)** 
Ref. 
13q22.1 3.6 
Hip 
associated 
with 
acetabular 
dysplasia 
Japan 
8 aff + 8 unaff 
1 family 
(Mabuchi  
et al. 2006)* 
14q23-31 2.23 
COMP, HA 
biomarkers 
Afr.Am / 
Nat. Am 
350 
1 extended family 
(Chen  
et al. 2010) * 
14q32.11 3.0 GOA 
Netherla
nds 
UK 
Japan 
370 
179 aff. siblings + 4 trios 
 
 
(Meulenbelt 
et al. 2008) 
15q21.3-
15q26.1 
p=0.04 
meta 
Knee, hip, 
hand 
European
+ 
USA 
3000 
893 families 
(Lee et al. 
2006) 
15q25.3 6.3 First CMC USA 
1214 / - 
267 families 
(Hunter  
et al. 2004) 
19q13.2 
and 
19q13.4 
4.3 
and 
4.0 
Tot-KL, 
hand 
and 
DIP 
UK 
1028 / - 
DZ twins 
(Livshits  
et al. 2007) 
19q13.3 1.8 
Tot-KL, 
hand 
USA 
1477 / - 
296 families 
(Demissie 
et al. 2002) 
20p13 3.7 
DIP 
(women) 
USA 
1214 / - 
267 families 
(Hunter  
et al. 2004) 
*Only one family; DIP = distal interphalangeal; GOA = generalized OA; OST = osteophyte; PIP = 
proximal interphalangeal; JSN = joint space narrowing; Tot-KL = Kellgren Lawrence score sum for both 
hands; CMC1 = carpometacarpal; TIP = thumb interphalangeal; European background including the 
USA; In the study by Chen et al. (2010), the phenotype correlates with visually graded hand OA (Chen 
et al. 2008). Overlapping studies: Lee et al. (2006) meta-analysis includes Chapman et al. 1999, 
Stefansson et al. 2003, Hunter et al. 2004; Demissie et al. 2002, Hunter et al. 2004; Loughlin et al. 1999, 
Loughlin et al. 2000, Loughlin et al. 2002b, Chapman et al. 1999, Forster et al. 2004, Southam et al. 2004; 
Meulenbelt et al. 2006, Meulenbelt et al. 2008. 
** the amount of individuals in screening / finemapping, and the amount of families or sibpairs used in 
the study; 
Table 1. Results from OA linkage studies. Modified from Kämäräinen (2009). 
The 2p23.3–24.1 region harboring the matrilin (MATN3) gene was shown to be significantly 
linked with hand OA (LOD = 4.4) in a study utilizing 1143 affected individuals and 939 
relatives in 329 families (Stefansson et al. 2003). The same region had been previously 
implicated by Demissie et al. (2002) in 296 families, but without genome-wide significance 
(LOD=2.2). A possible disease-causing variant was pinpointed in the MATN3 gene in the 
same study using 1312 cases and 873 controls, but the mutation was rare and did not fully 
explain the observed linkage.  
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A wide locus on 2q12-q34 has provided some evidence for linkage in four independent linkage 
studies: for DIP OA (Leppävuori et al. 1999), HIP OA (Loughlin et al. 2002a; Loughlin et al. 
2002b), thumb IP (Hunter et al. 2004), and generalized OA (Meulenbelt et al. 2006). Only 
evidence for generalized OA peaking at 2q33.3 was statistically significant and was also 
supported by a meta-analysis combining three previously published screens (Chapman et al. 
1999; Stefansson et al. 2003; Hunter et al. 2004; Lee et al. 2006). It is, however, unlikely that 
these linkage signals represent the same variant and none of the variants within this locus 
have yet provided convincing evidence for association, though several candidate genes with 
suggestive association have been reported: the neuropilin 2 gene (NRP2), p = 0.02; the 
“isocitrate dehydrogenase 1 (NADP+), soluble” gene (IDH1), p = 0.03 (Min et al. 2007); FRZB 
(Loughlin et al. 2004); and IL1R1 (Näkki et al. 2010). 
The 6p12-p11 region has shown significant evidence for linkage with hip OA in two 
overlapping UK screens conducted in 375 (Loughlin et al. 2002c) and 146 families (Southam 
et al. 2004). No significant OA-associated variants have been identified, but interestingly a 
variant (rs987237, TFAP2B) previously shown to associate with BMI (p = 2.90 × 10−20, n = 
195,776) maps within the linked region (Speliotes et al. 2010) - overweight being one of the 
known predisposing factors for OA. 
The loci on 7q35 and 15q25 were identified in a linkage screen for hand OA (n = 1216 study 
subjects in a DIP OA study) (Hunter et al. 2004) and were further replicated in a meta-
analysis extended with independent knee and hip OA families (in total n = 3000 knee, hip, 
and hand OA study subjects) (Chapman et al. 1999; Stefansson et al. 2003; Hunter et al. 2004; 
Lee et al. 2006). No OA predisposing variants have been identified. 
A region on 4q31-q32 has provided significant evidence for linkage with DIP (Stefansson et 
al. 2003) and hand OA (Livshits et al. 2007).  Further, the locus on 19q13 has shown 
significant evidence for linkage with hand and DIP OA (19q13.2 and 19q13.4, respectively, 
(Livshits et al. 2007) and this locus was also supported by a family based earlier linkage 
screen (Demissie et al. 2002). However to our knowledge, no significant OA predisposing 
variants have been identified within these loci.  
4. Candidate gene studies 
OA predisposing genes have been searched for through candidate gene studies, selecting 
genes based on their biological relevance or following a promising linkage study. Many of 
these genes participate in the cartilage extracellular matrix (ECM) 
composition/homeostasis by encoding structural proteins, matrix degrading enzymes, 
and different inflammatory mediator genes, as well as regulating signaling pathway 
genes. To date only a few of the putative positive findings in candidate gene association 
studies have been successfully replicated in an independent population, and the 
associated variants lack solid evidence for causality and functional differences between 
susceptibility alleles. For a review, see (Ikegawa 2007). In Table 2 we summarize those 
candidate genes that have shown the most suggestive evidence for association to OA. 
Replication of the initial finding in an independent study sample was used as a selection 
criterion. In addition, we will shortly describe genes with putative biological relevance to 
OA. They have shown suggestive association with OA in different candidate gene studies 
(for more details, see reviews by (Loughlin 2005; Bos et al. 2008; Ryder et al. 2008)), but 
have mostly not been confirmed.  
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Gene Locus Variation OA* 
Cases (n) /
Controls (n)
OR p-value Population Reference 
ACAN 
15q26 VNTR Ha 43 / 50 
3.23
(1.24-8.41)
<0.05 US 
(Horton et al. 
1998) 
 
VNTR/A27 Ha 112 / 153
0.46
(0.27-0.78)
0.012 Finnish 
(Kämäräinen et 
al. 2006) 
 
VNTR/A27 Ha tot. 134 na 0.04 Australian
(Kirk et al. 
2003) 
ASPN 
9q22.31 Allele D14 K 137 / 234
2.63
(1.5–4.7)
0.00084 Japanese
(Kizawa et al. 
2005) 
 
Allele D14 H 593 / 374
1.70
(1.1–2.5)
0.0078 Japanese
(Kizawa et al. 
2005) 
 
Allele D14 H 364 / 356
1.48
(1.09-2.01)
0.016 British 
(Mustafa et al. 
2005) 
 
Allele D14 K 218 / 454
2.04
(1.32-3.15)
0.0013 Chinese 
(Jiang et al. 
2006) 
Allele D14 K 354 / - na 0.004 Chinese (Shi et al. 2007) 
COL2A1 
12q13.1 
HT of HaeIII, 
HindIII
GOA 123 / 697
5.3
(2.2-12.7)
0.9983 Caucasian
(Meulenbelt et 
al. 1999) 
 
VNTR K 183 / 668p
2.06
(1.27-3.34)
na Caucasian
(Uitterlinden et 
al. 2000) 
 
HT of SNPs in 
exons 5, 32 and 
51
K/H 417 / 280
1.30 
(1.04-1.63)
0.024 Japanese
(Ikeda et al. 
2002) 
 
rs2276455 H 160 / 383
1.58
(1.05-2.36)
0.005 Finnish 
(Hämäläinen et 
al. 2009) 
ESR1 
6q25.1 PvuII, XbaI GOA 65 / 318 
1.86
(1.03-3.24)
0.039 Japanese
(Ushiyama et 
al. 1998) 
 
HT of PvuII, 
XbaI
K 
316 / 
1122p 
1.3
(0.9-1.7)
<0.01 Caucasian
(Bergink et al. 
2003) 
FRZB 
2q32.1 Arg324Gly H 378 / 760
1.50
(1.1–2.1)
0.04 British 
(Loughlin et al. 
2004) 
 
Arg200Trp and 
Arg 324Gly
H 558 / 760
4.10
(1.6–10.7)
0.007 British 
(Loughlin et al. 
2004) 
 
Arg324Gly G 545 / 1362
1.60
(1.1-2.3)
0.02 Dutch (Min et al. 2005) 
 
Arg200Trp and 
Arg 324Gly
H 570 / 1317
1.90
(1.22–2.96)
0.1 US 
(Lane et al. 
2006) 
 
Arg200Trp and 
Arg 324Gly
K 603 / 599
2.87
(0.92–8.95)
0.04 UK 
(Valdes et al. 
2007) 
GDF5 
20q11.22 rs143383 K 718 / 861
1.30
(1.10–1.53)
0.0021 Japanese
(Miyamoto et 
al. 2007) 
 
rs143383 H 1000 / 981
1.79
(1.53–2.09)
1.8x10-
13
Japanese
(Miyamoto et 
al. 2007) 
 
rs143383 K 313 / 485
1.54
(1.22–1.95)
0.00028 Chinese 
(Miyamoto et 
al. 2007) 
 
rs143383 K/H 
2487 / 
2018
1.28
(1.08–1.51)
0.004 
Spanish 
UK
(Southam et al. 
2007) 
 
rs143383 K/H 
1842 / 
1166
1.29
(1.14-1.47)
8x10-5 UK 
(Valdes et al. 
2009b) 
 
rs143383 Ha 604 / 1102
0.68
(0.54-0.85)
8x10-6 Dutch 
(Vaes et al. 
2009) 
 
rs143383 K 494 / 1174
0.68
(0.53-0.88)
0.003 Dutch 
(Vaes et al. 
2009) 
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Gene Locus Variation OA* 
Cases (n) /
Controls (n)
OR p-value Population Reference 
 
 
rs143383 H 
5,789 / 
7,850 
1.16 
(1.03–1.31)
0.016 
Caucasian
Japanese 
(8 cohorts)
(Evangelou et 
al. 2009) *** 
 
rs143383 K 
5,085 / 
8,135 
1.15 
(1.09–1.22)
9.4x 10-7
Caucasian
Japanese 
(10 
cohorts)
(Evangelou et 
al. 2009) *** 
 
rs143383 Ha 
4,040 / 
4,792 
1.08 
(0.96-1.22)
0.19 
Caucasian
Japanese 
(6 cohorts)
(Evangelou et 
al. 2009) *** 
IGF-1 
12q22-24 CA-repeat 
Ha/H
K/S
615 /135p
1.9
(1.2-3.1)
0.02 Caucasian
(Meulenbelt et 
al. 1998) 
 
CA-repeat 
Ha/H
K/S
1355/191p
1.4
(1.0-1.8)
0.03 Caucasian
(Zhai et al. 
2004) 
IL1B 
2q12-13 +3954C>T/TaqI K/H 61 / 254 
2.59
(1.4-4.7) 
0.0096 Caucasian
(Moos et al. 
2000) 
 
-511C>T/AvaI H 70 / 816p
1.5
(0.8-2.9) 
0.004 Caucasian
(Meulenbelt et 
al. 2004) 
 
+3954C>T/TaqI H 70 / 816p
0.6
(0.4-1.2) 
0.003 Caucasian
(Meulenbelt et 
al. 2004) 
 
5819G>A Ha 68 / 51 
3.82
(na) 
0.021 US 
(Stern et al. 
2003) 
 
rs1143634 Ha 165 / 377p
1.6
(1.08-2.26)
0.001 Finnish 
(Solovieva et al. 
2009) 
MATN3 
2p24.1 Thr303Met Ha 2162 / 873
2.12
(0.92-4.86)
na Iceland 
(Stefansson et 
al. 2003) 
 
Thr303Met Ha 50 / 356 
4.28
(1.18-14.8)
0.007 German
(Pullig et al. 
2007) 
ANP32A 15q23 rs7164503 H 
1,288 / 
1,741 
0.67
(0.53–0.84)
3.8x10-4
Caucasian
(4 cohorts)
(Valdes et al. 
2009a). 
SMAD3 
15q22 rs12901499 H 
1,288 / 
1,741 
1.22
(1.12-1.34)
7.5x10-6
Caucasian
(5 cohorts)
(Valdes et al. 
2010b) 
 
rs12901499 K 
1,888 / 
1,741 
1.22
(1.09-1.36)
4.0x10-4
Caucasian
(5 cohorts)
(Valdes et al. 
2010b) 
DIO2 14q31 rs225014 H 
1839 / 
2687 
1.79 
(1.37-2.34)
2.02x10
–5 
Caucasian
Japanese 
(4 cohorts)
(Meulenbelt et 
al. 2008) 
DIO3 14q32 rs945006 G 
3,252 / 
2,132 
0.81
(0.70-0.93)
0.04**
Caucasian
(4 cohorts)
(Meulenbelt et 
al. 2011) 
VDR 
12q12-14 I365I, TaqI K 82 / 269p
2.60
(1.01-6.71)
<0.05 Caucasian
(Keen et al. 
1997) 
 
HT of BsmI, 
ApaI, TaqI 
K 179 / 667p
2.31 
(1.48-3.59)
0.005 Caucasian
(Uitterlinden et 
al. 1997; 
Uitterlinden et 
al. 2000) 
aAssociation for early onset OA; 3 Association for joint involvement and disease severity;  *G = 
generalized; Ha = hand; K = knee; H = hip; na = not available; population based study; HT=haplotype, 
A27=27 repeats;** = permutation based; *** = including Vaes et al. 2008, Valdes et al. 2008, Southam et 
al. 2007, Miyamoto et al. 2007; bold font indicates region with linkage finding 
Table 2. Candidate gene studies  
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The first structural genes analyzed were genes coding for major cartilage collagens II, IX, 
and XI, where mutations causing Stickler syndrome, a mild chondrodysplasia associated 
with OA, have been identified (for a review, see Robin et al. (2010)). Earlier reports 
suggested linkage between COL2A1 and OA in two large families (Palotie et al. 1989; 
Vikkula et al. 1993), and a causal Arg519Cys mutation in the 1(II) chain was identified in 
OA families (Ala-Kokko et al. 1990; Fertala et al. 1997). In addition rare sequence variants in 
the genes for collagens II and XI have been associated with hip/knee OA (Jakkula et al. 
2005). Several mutations have been identified in the collagen IX genes in patients with MED, 
a mild chondrodysplasia characterized by early-onset OA (Paassilta et al. 1999; Czarny-
Ratajczak et al. 2001; Briggs et al. 2002). The roles of these genes are indisputable in mild 
chodrodysplasias, but so far only suggestive evidence for different common variants 
predisposing to OA have been reported (Ikeda et al. 2002; Hämäläinen et al. 2008; Näkki et 
al. 2011), none of which have yet been confirmed. Interestingly, mutations causing MED 
have also been identified in the vWF domain of the MATN-3 gene (Chapman et al. 2001), 
which has been suggestively associated with OA later in a linkage and association study. 
The chromosomal region of 2p23.3–24.1 harboring the MATN3 gene was shown to be 
significantly linked with hand OA (LOD = 4.4) in a study utilizing 1143 affected individuals 
and 939 relatives (Stefansson et al. 2003). A possible disease-causing variant was pinpointed 
in MATN3. Matrilins are ECM proteins expressed in the developing skeletal system. 
MATN3 is mostly restricted to developing cartilage, especially the epiphyseal cartilage 
(Stefansson et al. 2003). The expression of MATN3 has been shown to be enhanced in OA 
cartilage of humans (Pullig et al. 2002).  
Aggrecan (AGC1, ACAN) is the most abundant proteoglycan in cartilage and is an essential 
molecule for its osmotic properties (Roughley et al. 1994). Aggrecan gene transcription was 
shown to be elevated in early osteoarthritis in STR/ort mice (Gaffen et al. 1997). It contains a 
large polymorphic VNTR region that has been a target for several association studies, as it 
provides the attachment sites for numerous glycosaminoglycan side chains. Some level of 
association between ACAN and OA has been shown, but the results have been inconsistent 
(Horton et al. 1998; Kirk et al. 2003; Kämäräinen et al. 2006). 
The transforming growth factor-ǃ (TGF-ǃ) signaling pathway has provided interesting 
candidate genes for OA, such as asporin (ASPN), which binds to TGF-ǃ and suppresses the 
expression of both ACAN and COL2A1 and reduces proteoglycan accumulation (Kizawa et 
al. 2005). Asporin is expressed in human osteoarthritic cartilage at high levels, but is barely 
detectable in cartilage of healthy individuals (Kizawa et al. 2005). The association between 
ASPN and knee/hip OA was first found in a Japanese population by Kizawa et al. (2005) 
and then replicated for knee OA by Nakamura et al. (2007) in a meta-analysis combining 
Europeans and Asians (p = 0.003, summary OR 1.46 with significant heterogeneity 
(p=0.047)). After stratification, association of the ASPN D14 allele with knee OA was seen 
only in the Asian populations. It is difficult to prove whether there is a true ethnical 
difference seen in the study, since there were also differences in the patient selection criteria 
between different ethnic populations.   
Another member of the TGF-ǃ superfamily is GDF5, growth and differentiation factor 5, 
which is closely related to the subfamily of bone- and cartilage-inducing molecules called 
the bone morphogenetic proteins (BMPs). GDF5 seems to induce cartilage and bone 
formation and stimulate de novo synthesis of proteoglycan ACAN (Erlacher et al. 1998). 
Mutations in this gene cause skeletal alterations both in humans (Thomas et al. 1996) and in 
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mice (Storm et al. 1994). GDF5 was first associated with hip and knee OA in Asian 
populations (1000 hip OA cases, 984 controls, p = 1.8 x 10-13) (Miyamoto et al. 2007), and the 
knee OA finding was replicated in a large meta-analysis (5085 knee OA cases and 8135 
controls; OR 1.15, 95% CI 1.09-1.22, p = 9.4x10-7, Table 4) (Evangelou et al. 2009). 
Participation of the TGF-ǃ pathway was suggested also by a recent meta-analysis where the 
rs12901499 SNP in the SMAD3 gene showed association with hip OA in a study utilizing 
five OA cohorts (1288 hip OA cases, 1741 controls; OR = 1.22, 95% CI 1.12-1.34, p < 7.5 x 10-6) 
and a similar trend was seen in knee OA (1888 knee OA cases, 3057 controls; OR = 1.22, 95% 
CI 1.09-1.36, p < 4.0 x 10-4) (Valdes et al. 2010b). SMAD3 has been suggested to act as an 
effector of the TGF-beta response (Zhang et al. 1996). SMAD3 is located in chromosomal 
area 15q22.33 previously linked with OA: 15q21.3-15q26.1 with a p-value of 0.04 (Lee et al. 
2006) and 15q25.3 with a LOD score of 6.3 (Hunter et al. 2004). In the same chromosomal 
region, ANP32A has been suggestively associated with hip OA in a study utilizing four 
patient cohorts (meta-analysis p = 3.8x10-4) and it was suggested to play a role in increased 
chondrocyte apoptosis (Valdes et al. 2009a). In mice, the over-expression of the Smurf2 gene 
seems to lead to dephosphorylation of Smad3 and cause the spontaneous OA phenotype 
(Wu et al. 2008).  
The Wnt (wingless) signaling pathway that is involved in skeletal and joint patterning in 
embryogenesis has also raised interest in OA genetic studies. Previously, James et al. 
(2000) suggested that a member of this family, FrzB-2, may play a role in apoptosis and 
that the expression of this protein may be important in the pathogenesis of human OA. 
FRZB is a soluble antagonist of Wnt signalling and the gene showed some association 
with hip OA in a study by Loughlin et al. (2004) among others. However, the association 
could not be confirmed in a meta-analysis by Kerkhof et al. (2008) or in a large-scale 
association analysis of 5789 cases and 7859 controls with two FRZB variants (Evangelou 
et al. 2009), as the latter study revealed only a borderline association for hip OA  
(p = 0.0199).  
The inflammatory cascade in OA cartilage is a widely studied topic in OA genetics. Interleukin 
1 (IL-1) and tumor necrosis factor ǂ (TNF-ǂ) have been shown to inhibit collagen II production 
in chondrocytes by activating signaling pathways c-Jun N-terminal kinase (JNK), p38 mitogen-
activated protein kinase (p38 MAPK), and nuclear factor kappa B (NF-κB) (Robbins et al. 2000; 
Seguin et al. 2003). Mechanical stress can also activate these pathways. The interleukin-1 gene 
family cluster is located on chromosome 2q12-13, and several association studies have shown a 
possible role for these genes in hip, knee, or hand OA (Moos et al. 2000; Loughlin et al. 2002a; 
Meulenbelt et al. 2004; Solovieva et al. 2009; Näkki et al. 2010). Individual associations have not 
been replicated, however. Kerkhof et al. (2011a) performed a meta-analysis to clarify the role of 
the common variants in the IL1B and IL1RN genes on the risk of knee and hip OA. No 
evidence of association was seen for individual variants (p > 0.05), but a suggestive association 
with reduced severity of knee OA was seen for a CTA-haplotype (rs419598, rs315952, and 
rs9005; OR 0.71, 95 % CI 0.56-0.91, p = 0.006).  
Interleukin 6 (IL-6) is a pleiotropic proinflammatory cytokine that is markedly up-
regulated in tissue inflammation. There is plenty of biological evidence of its role in OA 
pathogenesis. A significant rise in the level of IL-6 mRNA has been detected in OA-
affected cartilage, and IL-6 levels in the serum and synovial fluid have been reported to be 
elevated among OA patients (Kaneko et al. 2000). Additionally, IL-6 knockout mice 
develop more severe OA than wild-type animals (de Hooge et al. 2005). Genetic analyses 
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have not been able to show compelling evidence for any of the common variants in IL-6 
with OA, however. IL-6 promoter variant rs1800795 has been found to correlate for 
example with pain sensation in rheumatoid arthritis (p = 0.014) (Oen et al. 2005), and 
there is initial evidence for its association in a small set of symptomatic hand OA cases 
(OR 1.52, 95% CI 1.5-9.0, p = 0.004) (Kämäräinen et al. 2008). A recent meta-analysis of this 
SNP, however, (1101 hip OA patients, 1904 knee OA patients, and 2511 controls) showed 
no evidence for association with the risk of hip and knee osteoarthritis (p = 0.95 and p = 
0.30, respectively) (Valdes et al. 2010a), although the study sample had 80 % power to 
observe association with the OR 1.12 for hip and OR 1.10 for knee OA with p < 0.05. IL-6 
has been reported to contribute to the disease symptoms in rheumatoid arthritis and in 
OA ((Kaneko et al. 2000; Cronstein 2007), respectively), and as Valdes et al. (2010a) point 
out, confirming the lack of genetic association does not imply a lack of involvement in 
disease. In addition, IL4R has a known role in cartilage homeostasis by affecting 
inflammation due to mechanical stress. Common variants in this gene have shown 
suggestive evidence for association with OA (OR 2.1, 95 % CI 1.3-3.5, p = 0.004) (Forster et 
al. 2004a), but the associations have not been confirmed.  
In OA, the degradation of cartilage ECM exceeds its synthesis and the primary cause has 
been suggested to be an increase in proteolytic enzyme activity, since aggrecan cleavage 
products accumulate in the synovial fluid of OA patients (Sandy et al. 1992). Two 
aggrecanases, ADAMTS4 and ADAMTS5, are expressed in human OA cartilage and localize 
in the areas of aggrecan depletion, and have the highest specific activity for aggrecan 
cleavage in vitro (Tortorella et al. 2002). Suppression of both enzymes by siRNA reduces 
aggrecan degradation (Song et al. 2007). Tetlow et al. (2001) showed that several matrix 
metalloproteinases (MMPs 1, 3, 8, and 13), IL-1ǃ, and TNF-ǂ are present in the superficial 
zone of OA cartilage, where the chondrocyte clusters are located and where degenerative 
matrix changes appear. Matrix metalloproteinases break down collagens and MMP-13 is 
specialized in breaking the type II collagen.  
In a study by Meulenbelt et al. (2008), a suggestive association between hip OA and 
variant rs225014 (Thr92Ala) in the iodothyronine-deiodinase enzyme type II gene (DIO2) 
was detected in 1839 hip OA cases and 2687 controls from Asia and Europe. The variant 
was located in close proximity to the linkage region on 14q32.11 (LOD 3.03). Some 
association was observed in four independent OA study samples of females with 
Caucasian and Asian background, and an OR = 1.79 (95% CI 1.37–2.34; p = 2.02 x 10–5) was 
obtained for rs225014 and rs12885300 haplotypes. The authors hypothesized that the link 
between this gene and OA is the role of DIO2 in one of the following: endochondral 
ossification, OA progression, or inflammatory pathways including NFκB. The gene 
product of DIO2 participates in the regulation of intracellular levels of active thyroid 
hormone (T3) in target tissues such as the growth plate. A meta-analysis of genes 
modulating intracellular T3 bioavailability has shown a role for another gene, deiodinase 
iodothyronine type III (DIO3), in OA (Meulenbelt et al. 2011). A total of 3252 
hip/hand/knee cases and 2132 controls were studied and the suggestive association was 
seen with variant rs945006 for knee and/or hip OA (OR 0.81, 95 % CI 0.70-0.93, p = 0.004, 
permutation-based corrected p = 0.039). 
Several studies have investigated the role of the vitamin D receptor gene (VDR) in OA. 
Restriction enzyme polymorphisms have been suggestively associated with knee and hand 
OA in limited sample sets (Keen et al. 1997; Uitterlinden et al. 1997; Uitterlinden et al. 2000; 
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Solovieva et al. 2006). However, a meta-analysis of ten studies on VDR polymorphisms and 
OA provided no evidence of association (Lee et al. 2009). The studies used in the meta-
analysis differed in respect to the site of OA involvement, and heterogeneity in clinical 
features such as age and sex, which both affect the development of OA, and was recognized 
by the authors. 
The role of variants in the estrogen receptor genes (ESR1, ESR2) has also been studied in 
OA. The role of estrogen may be important in OA since estrogen has been shown to be 
chondrodestructive via a receptor-mediated mechanism, and estrogen receptors are found 
in canine, rabbit, and human articular cartilage (Tsai et al. 1992). Suggestive association of 
restriction polymorphisms in ESR1 has been detected in three studies (Ushiyama et al. 
1998; Bergink et al. 2003; Jin et al. 2004). A meta-analysis of 2364 hip, 1983 knee, and 1431 
hand OA cases and 6773, 4706, and 3883 controls, respectively, was performed for 
variants in ESR2.  Variant rs1256031 showed some evidence for association with increased 
risk for hip OA in women (OR 1.36, 95 % CI 1.08-1.70, p = 0.009), but the combined 
analysis with knee and hand OA data did not show evidence for this variant (OR 1.06, 95 
% CI 0.99-1.15, p = 0.10). The study had 80 % power to detect an OR of at least 1.14 for hip 
OA (ǂ=0.05).  
5. Genome-wide association studies 
Single nucleotide variants (SNPs) and information on the linkage disequilibrium (LD) 
structure between them identified by the HapMap and 1000 Genomes projects (Gibbs et al. 
2003; Frazer et al. 2007; Durbin et al. 2011; Patterson 2011), as well as significant 
advancements in commercially available genotyping methods, have enabled development 
of genome-wide SNP arrays capable of genotyping a few hundred thousands to up to 
millions of evenly distributed variants within the genome at a reasonable cost in large 
amounts of samples.  Genome-wide association studies (GWAS) have the advantage of not 
requiring knowledge and hypotheses on the gene functions beforehand, since the whole 
genome is under investigation in a systematic manner. GWAS analyses have proven a 
highly effective approach for identifying disease predisposing variants for common familial 
diseases (Wellcome Trust Case Control Consortium 2007). 
The increased number of SNPs on arrays in recent years has improved the coverage of the 
common and especially the non-frequent variants; however, all common variations are still 
not fully covered. The increase in the number of SNPs represented on the arrays has also 
significantly increased the amount of association tests conducted in a project, thus making 
multiple testing correction and utilization of strict thresholds for statistically significant 
association very critical to avoid a multitude of false positive findings. The statistical 
significance threshold for the p-value suggested by the Wellcome Trust Case Control 
Consortium in 2007 was p < 5x10-7 (2007), while the current broadly accepted threshold for 
genome-wide significance is p < 5x10-8. The high quality genotype data produced from the 
commercially available arrays has also enabled the collection of sufficiently large data sets, 
which is a prerequisite for reliably identifying predisposing variants with low Odds Ratios 
(OR 1.1-1.5) typically seen in common, multi-factorial diseases (Manolio et al. 2009). 
Altogether four high density GWAS and one meta-analysis of GWAS have been conducted 
for OA phenotypes and the GWAS approach has proven to be a useful tool also in OA 
(Table 3). Three of the four genome-wide significant or highly probable OA predisposing 
variants have been identified by GWAS (Table 4).  
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Phenotype Screening 
cases / controls, 
screening 
(population)* 
Replication 
cases / controls, 
replication 
(population)** 
Platform in screening 
phase 
Ref 
Hip: 
Radiological + 
clinical 
93 / 631 
(Japanese) 
426 / 1006 
(Japanese) 
71,880 SNPs (Mototani 
et al. 2005) 
Knee: 
radiological, 
clinical 
94 / 658 
(Japanese) 
1,399 / 2,141 
(Japanese, Chinese) 
99,295 SNPs 
The multiplex PCR–
based Invader assay28 
(Third Wave 
Technologies) 
(Miyamoto 
et al. 2008) 
Hand: radiological 1804 in total 
(UK, Dutch) 
3266 in total 
(UK, Dutch, 
Caucasian from 
Russian Federation 
autonomous regions)
Illumina HumanHap 
317 k 
Illumina HumanHap 
550 k 
(Zhai  
et al. 2009) 
Hip: radiological or 
TJR 
Knee: radiological 
or TJR 
Hand: The 
American College 
of Rheumatology 
hip + knee + hand: 
248 + 515 + 578 / 
1,411 + 1,047 + 1,038 
(European ancestry: 
Dutch) 
5,720 + 4,066 + 3,811/
39,000 controls 
(European ancestry)
Illumina HumanHap 
550v3 k 
Infinium HumanHap 
300 k 
Affymetrix GeneChip 
Human Mapping 
(Kerkhof 
et al. 2010) 
Knee: 
radiological, 
clinical 
906 / 3,396 
(Japanese) 
1,879 / 4,814 
(Japanese, European 
ancestry) 
Illumina HumanHap 
550 k 
(Nakajima 
et al. 2010) 
Hip and knee: 
radiological, 
clinical 
3177 /  4894 
(UK ) 
~60.000 
(European) 
Illumina Human610 
platform 
Illumina 1.2M Duo 
platform 
(Panoutso
poulou  
et al. 2011) 
Knee: 
radiological, 
clinical 
2,371 / 35,909 
(European ancestry: 
Icelandic, Dutch, UK, 
USA) 
6,709 / 44.439 
(European ancestry)
Illumina HumanHap 
550v3 k 
Infinium HumanHap 
300 k 
Affymetrix GeneChip 
Human Mapping 
(Evangelo
u et al. 
2011) 
* In the screening phase, the nationality of the studied population is specified. 
** Including the screening sample 
Table 3. GWA studies performed in OA 
Mototani and coworkers (2005) conducted a low density genome wide analysis by testing 
over 70,000 gene-based SNP markers for association with hip OA. The initial screening 
phase revealed a variant in the calmodulin 1 CALM1 gene (rs3213718, IVS3 - 293C > T) on 
14q24–q31 that showed some association in the small Japanese case-control set (OR=2.51, 
95 % CI 1.40–4.50; p=0.0015). A replication in 334 individuals with hip OA and 375 control 
subjects provided a p-value of p=0.00065, (OR=2.40, 95 % CI 1.43–4.02) but when the 
reported genotype count data is combined into a meta-analysis, there is no genome wide 
significance (OR=1.35, 95 % CI 1.12-1.62; p = 0.0015, The Plink program (Purcell et al. 
2007)).  
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The s3213718 SNP did not associate with knee OA in two low-powered Caucasian cohorts  
(298 male cases/300 male controls and 305 female cases, 299 female controls) (Valdes et al. 
2007). Another SNP initially associating with hip OA in the Japanese study (rs12885713: 303 
cases, 375 controls; OR = 2.56, 95 % CI  1.50–4.36, p = 0.00036) did not replicate in a study of 
920 Caucasian hip OA cases and 752 controls, which had 97 % power to detect the original 
association  (Loughlin et al. 2006). This might be due to a false positive original finding or 
due to substantial differences in the phenotypes, 40 % of the Japanese cases suffering from 
acetabular dysplasia (Hoaglund 2007). 
Two GWA studies utilizing pooled knee OA and control DNA samples have been 
conducted. First, a low density genome-wide analysis of 25 494 SNPs located within gene 
regions utilizing pooled DNA samples of 335 female knee OA cases and 335 female controls 
was performed (Spector et al. 2006). The most significant SNPs were individually genotyped 
in the same samples and those with the most consistent difference were also genotyped in 
two replication sets of 1124 cases and 902 controls. One variant (rs912428a) in the LRCH1 
gene on chromosome 13 showed the most consistent difference in the replication samples, 
but the association was not significant after correcting for multiple testing (OR of 1.45, and a 
p-value < 5 x10-4 in the analysis combining the screening and the replication sets). 
A high-density GWAS was also conducted utilizing pooled samples. A three-phase study 
used a chip containing over 500 000 genome-wide variants to screen pools of 357 female 
knee OA cases and 285 female controls, replicated the most significant 28 variants in 871 
knee OA cases and 1788 controls, and further validated seven variants in an additional 306 
cases and 584 controls (Valdes et al. 2008). None of SNPs reached genome-wide significance 
in the screening phase, but one variant (rs4140564) located in an LD block containing the 
PTGS2 and PLA2G4A genes, which are involved in the prostaglandin E2 synthesis pathway, 
provided quite convincing evidence for association in the combined analysis of the 
screening and the replication samples (OR 1.55 (95% CI 1.30–1.85), p = 6.9 x 10-7).  
A second low density genome-wide analysis utilizing individually genotyped cases and 
controls was conducted in a limited sample of 94 knee OA cases and 658 controls of Japanese 
origin using approximately 100 000 SNPs (Miyamoto et al. 2008). Fine-mapping of the initially 
identified susceptibility locus and further validation in independent OA cohorts revealed 
variants with genome-wide significant association to knee OA (a combined p-value of 7.3 x 10-
11 with an OR of 1.43 (95% CI 1.28–1.59 for rs7639618). Re-sequencing of the novel DVWA gene 
identified three putatively functional SNPs: two missense SNPs, rs11718863 (encoding Y169N) 
and rs7639618 (encoding C260Y), and rs9864422 located in intron 1. The two coding variants 
were in almost complete LD and one of the four observed haplotypes (Tyr169-Cys260) was 
significantly overrepresented in osteoarthritis and was found to bind ǃ-tubulin weaker than 
the other three isoforms in a in vitro functional assay. Later, Wagener and co-workers 
(Wagener et al. 2009) suggested that the DVWA might actually represent the COL6A4 gene, 
but according to current RefSeq annotation it is a transcribed pseudogene and represents the 5' 
end of a presumed ortholog to a mouse gene encoding a collagen VI alpha 4 chain protein 
(UCSC Genome Browser, GRCh37/hg19; http://genome.ucsc.edu/). Association of the 
variants in the DVWA gene was not replicated in a follow-up analysis of 1120 European knee 
OA cases and 2147 controls, which  had approximately 96 % power  to observe an association 
with an effect size (OR= 1.43) reported in the combined Japanese and Chinese population and 
an allele frequency of 0.14 in cases) (Meulenbelt et al. 2009). Whether the lack of association is 
due to a limited sample size and overestimation of the effect size in the original publication, 
www.intechopen.com
  
Principles of Osteoarthritis – Its Definition, Character, Derivation and Modality-Related Recognition 
 
300 
difference in the phenotypes, heterogeneity in different populations, or a false positive initial 
finding, requires further analysis in a significantly large sample cohort.  
A larger GWAS in a Japanese population genotyped over 500 000 SNPs in 906 knee OA 
cases and 3396 controls (Nakajima et al. 2010). Replication of the 15 SNPs with a p-value 
smaller than 1x10-5 in the initial screen in an independent Japanese cohort identified two 
SNPs (rs7775228 and rs10947262) showing genome-wide significant evidence for association 
in a combined analysis (p = 2.43x10-8, OR= 1.34; 95% CI = 1.21–1.49 and p = 6.73x10-8; OR= 
1.32; 95% CI = 1.19–1.46, respectively). The two SNPs were in high LD with each other and 
were located within a 340-kb region within the HLA locus, including BTNL2, HLA-DRA, 
HLA-DRB5, HLA-DRB1, HLA-DQA1, and HLA-DQB1. Most of the genes within the 
associated region belong to the HLA class II molecules, which are expressed in antigen 
presenting cells and play a central role in the immune system by presenting peptides 
derived from extracellular proteins. The BTNL2 gene encodes butyrophilin-like 2, which 
negatively regulates T-cell activation. The variant rs10947262 in the BTNL2 gene showed 
nominal evidence for association also in a European cohort and provided a p-value of 
5.10x10-9 in a meta-analysis combining the Japanese and European data. The authors did not 
report whether the previously identified variants in the DVWA gene (Miyamoto et al. 2008) 
were tagged by the SNPs in the array and showed no evidence for association in the screen.  
Over 300 000 genome-wide variants were analyzed for association to hand OA in the 
TwinsUK cohort, which had radiographs of both hands available for 799 subjects (Zhai et al. 
2009). None of the SNPs achieved significant evidence for association in the first screening 
phase, and the top 100 SNPs were selected for further analysis in a part of the Rotterdam 
cohort with both genotype and hand OA data available. Of the five SNPs nominally 
replicated in the second cohort, none were significantly associated with hand OA in the 
meta-analysis combining the two screening and four additional replication cohorts. The 
strongest evidence for association was observed with an SNP rs716508 located in the intron 
of the A2BP1 gene (p = 4.75 x10-5), but did not reach genome-wide significance.  
A high density GWAS of over 500 000 SNPs was aimed at identifying variants associated 
with a generalized OA (Kerkhof et al. 2010). In total, 1341 Dutch OA cases and 3496 Dutch 
controls were utilized in the screen, and SNPs associated with at least two OA phenotypes 
were analyzed in 12 additional cohorts including 14 938 independent OA cases and 39 000 
controls in total. Of the twelve top hits analyzed in the replication cohorts, one variant 
(rs3815148) located in COG5 on chromosome 7 was significantly associated with hand 
and/or knee OA in the meta-analysis combining screening and replication cohorts (p = 8x10-
8, OR 1.14, 95% CI 1.09-1.19). Variants in the previously identified GDF5 gene (Miyamoto et 
al. 2007) showed evidence for association to hand OA in the screening phase (p = 1x10-5), but 
the variant (rs6088813) provided only a p-value of 0.01 in the replication, although there 
were 8970 hand and/or knee of cases and almost 40 000 controls included in the analysis. 
None of the other previously identified OA variants were included in the replication effort. 
Although the authors monitored for their association in the screening cohort, it had only a 
limited power to observe the association. Variants rs225014 and 12885300 in the DIO2 gene 
were reported not to associate with hip OA in the Rotterdam Study, but they showed a 
trend towards the same direction observed in the original publication (Meulenbelt et al. 
2008). The SNPs rs4140564 in PTGS2 (Valdes et al. 2008) and rs7639618 in DVWA (Miyamoto 
et al. 2008) showed no evidence for association with knee OA in the to some extent 
undersized Rotterdam cohort. 
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Panoutsopoulou and co-workers (2011) conducted a GWAS of knee and hip OA with over 
500 000 SNPs in 3,177 cases and  4,894 controls in the screening phase and almost 60,000 
study subjects in the replication phase. Variant rs4512391 near the TRIB1 gene showed the 
strongest association with combined hip and knee OA (OR=1.17, 95% CI 1.10-1.25; 
p=1.8×10−6) and with knee OA (OR = 1.23, 95% CI 1.13-1.33; p = 1.1×10−6) and rs4977469 in 
FAM154A with hip OA (OR = 1.30, 95% CI 1.17- 1.45; p = 1.2×10−6) in the initial screen. 
However, none of the SNPs included in the replication (p<10-4) reached genome-wide 
significance in the analysis combining the screening and the replication data. The screening 
cohort had limited power to detect association with common variants with low Odds Ratios, 
thus the previously identified OA variants were not systematically followed-up. Yet, a few 
variants in biologically interesting genes providing suggestive evidence for association in 
the combined analysis (p-values between 1.2×10−6 and 7.59x10-5 ) were brought up in the 
discussion (rs13026243 in NRP2, rs7626795 in IL1RAP, rs2819358 in ELF3, rs2280465 in 
ACAN, rs2615977 in COL11A1).  
The meta-analysis of GWAS for knee OA combined the data of the four previously 
published GWAS including in total 2371 knee OA cases and 35 909 controls of Caucasian 
origin in the screening phase (Evangelou et al. 2011). Altogether 11 SNPs (p-value < 5x10-5) 
in 10 different loci were replicated in 3326 cases and 7691 controls from eight European 
populations. Only two SNPs (rs4730250 and rs10953541), which are located in the previously 
identified 500 kb LD block on chromosome 7q22 containing six genes, replicated nominally 
in the combined analysis of the follow-up samples and showed genome-wide significant 
evidence for association with OA in the analysis combining the meta-analysis GWAS data 
and 10 replication cohorts of European origin (p = 9.2x10-9, OR 1.17, 95% CI 1.11-1.24) for 
rs4730250. No evidence for either heterogeneity in the effect size between populations or 
gender-specific effects was observed. The association was not significantly replicated in an 
East-Asian cohort of 1183 knee OA cases and 1245 controls, which, however, had a limited 
power to observe an association of the effect size seen in the European populations (power 
of 6% when assuming MAF of 0.15 in controls based on HapMap). The meta-analysis 
combining the European and Asian samples yielded a global summary effect of 1.15 and 
showed no evidence of heterogeneity. The most significant variant rs4730250 is in high LD 
with rs10953541 (r2=0.63, D’=1 in HapMap-CEU) and with the previously identified variant 
rs3815148 (r2=0.77, D’=1 in HapMap CEU), and thus all three are likely to represent the 
same underlying association signal. None of the other previously confirmed OA variants 
yielded a p-value < 5x10-5, and were not followed up. This likely reflects the limited power 
of the meta-analysis, but may also indicate heterogeneity between the phenotypes or 
between European and Asian populations in at least some of the OA susceptibility variants. 
As for the other confirmed OA loci, the predisposing gene/variant within the 7q22 locus 
remains yet to be defined. The associated 500 kb LD block contains six genes: DUS4L, COG5, 
GPR22, BCAP29, PRKAR2B, and HPB1. DUS4L encodes for a tRNA-dihydrouridine synthase 
4-like. The protein encoded by COG5 is one of eight proteins which form a Golgi-localized 
complex required for normal Golgi morphology and function (Ungar et al. 2002). Mutations 
in COG5 have been shown to result in congenital disorder of glycosylation type 2I (Paesold-
Burda et al. 2009). GPR22 encodes for a G protein-coupled receptor 22, which belongs to a 
family of the G-protein coupled receptors (O'Dowd et al. 1997). BCAP29 encodes for a B-cell 
receptor-associated protein 29. The Bap29/31 complex has been shown to influence the 
intracellular traffic of MHC class I molecules (Paquet et al. 2004). PRKAR2B encodes for a 
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cAMP-dependent protein kinase, which is a signaling molecule important for a variety of 
cellular functions. HPB1 encodes for a HMG-box transcription factor 1, which is a 
transcriptional repressor regulating the cell cycle and of the Wnt pathway (Sampson et al. 
2001). 
 
Chr. Variant 
Putative 
gene 
Predispo-
sing allele 
/Freq 
p 
OR 
(95 % CI)
Study 
population: 
cases/controls 
Ref 
3p24 rs7639618
DVWA/ 
COL6A4P1
CAPN7 
C / 0.64 7.3x10-11
1.43 
(1.28–1.60)
1,399 knee / 
2,141 
Asian 
(Miyamoto 
et al. 2008) 
6p21 
rs10947262
(rs7775228)
BTNL2 
HLA-DQB1
HLA-DRA 
HLA-DRB5
HLA-DRB1
HLA-DQA1
HLA-DQB1
HLA-DRB3
HLA-DRB4
C / 0.58 5.1x10-9
1.31 
(1.20–1.44)
1,879 knee / 
4,814 
Asian & 
European 
(Nakajima 
et al. 2010) 
7q22 
rs4730250 
(rs3815148) 
(rs10953541)
DUS4L 
COG5 
GPR22 
BCAP29 
PRKAR2B 
HPB1 
G / 0.17 9.2x10-9
1.17 
(1.11-1.24)
6,709 knee / 
44.439 
European 
(Evangelou 
et al. 2011) 
(Kerkhof et 
al. 2010) 
20q11 rs143383 
GDF5 
UQCC 
CEP250 
T / 0.26 1.8x10-13
1.79 
(1.53–
2.09) 
998 hip / 
983 
Asian 
(Miyamoto 
et al. 2007) 
Chr = chromosome; variant= rs number of the most significant reported variant (other reported variants 
shown in the parenthesis), p-value = combined p-value of screening and replication; OR = odds ratio; 
Study population= number of cases/controls utilized in the analysis providing the most significant p-
value, OA= generalized OA, knee= knee OA, hip= hip OA, All findings were identified by a GWAS 
approach, except rs143383 in GDF5, which was identified by a candidate gene study.  
Table 4. Loci with genome-wide significant evidence for association (p < 5x10-8) with OA. 
6. Other approaches 
There have not been sufficiently large, systematic genome-wide expression studies on 
human cartilage samples to undoubtedly confirm or exclude any expression patterns in OA 
cartilage. Some examples of alternative approaches are shortly described below. 
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Genome-wide expression profiling by Karlsson et al. (2010) of healthy (n = 5) and 
osteoarthritic cartilage (n = 5) revealed several genes up- or downregulated in OA cartilage. 
The study analyzing over 47 000 transcripts suggested changes for several gene families:  
cytokines, such as the tumor necrosis factors (TNF), chemokines like interleukin 8 (IL8), 
enzymes like matrix metalloproteinase (MMP), growth factors like insulin growth factor 
(IGF), matrix components like collagen I (COL1), and others such as HLA-DQA1. 
In the first serum-based metabolomic study of osteoarthritis in humans, the ratio of two 
branched-chain amino acids, valine and combination of leusine and isoleucine, to histidine 
was significantly associated with the disease. The study was conducted in 123 + 76 knee OA 
cases and 299 + 100 controls by analyzing 163 serum metabolites (Zhai et al. 2010). 
In a candidate biomarker study using blood samples (n = 287), hyaluronan (HA), cartilage 
oligomeric matrix protein (COMP) and collagen IIA N-propeptide (PIIANP), high sensitive 
C-reactive protein (hs-CRP), and glycated serum protein (GSP) showed an association (p < 
0.05) with clinical phenotypes of hand OA or hand symptoms, of which PIIANP (0.57), HA 
(0.49), and COMP (0.43) showed some level of heritability (Chen et al. 2008). PIIANP is a 
marker of a fetal form of collagen II recapitulated in OA (Chen et al. 2008). The COMP 
molecule binds to the collagenous structure in cartilage and can initiate the alternative 
complement pathway (Happonen et al. 2010). HA has a role in cartilage structure as well.  
7. Conclusions 
Earlier studies have shown the importance of some structural genes in familial OA, but their 
role in predisposition to common forms of OA remains unclear. It is possible that there are 
rare mutations with high risk for OA affecting single families (or individuals), and perhaps 
there are more common alleles with smaller effects functioning at the population level. In 
population-based genome wide association studies utilizing common variants a handful of 
genes have been confirmed to affect OA (Table 4), however these studies have not revealed 
additional evidence that common variants in the earlier candidate genes associate with OA. 
The few confirmed genome-wide significant gene variants in OA (Table 4) locate in or near 
genes that have a role in cell signaling and immunity. For practically all the recognized 
variants, the functional gene and the predisposing variant is still unknown due to the LD 
structure of the pinpointed area, thus the mechanism how these loci increase OA 
susceptibility is yet unknown.  The causative gene might not be located in close proximity to 
the observed variant, but the variant might also affect the gene expression of genes further 
away in the genome. 
As presented in the current review, false positive findings and limited power are issues in 
many genetic studies of common diseases. In general the power to detect predisposing 
variants depends on the effect size of the single variant to the disease. The smaller the effect 
of one variant to the disease the larger the study sample that is needed to observe the effect. 
Usually in complex diseases the effect size of any single variant is very small thus small 
effect variants will be missed and negative findings do not exclude the role of a variant to 
the studied trait (Purcell et al. 2003). A positive finding from an association study could 
mean that a disease-causing or predisposing variant has been found or a variant in high LD 
with the true disease-causing or predisposing variant has been identified. However, many 
aspects in gene mapping need to be taken into account when interpreting the results.  
One of the challenges in genetic studies is population stratification, which occurs when the 
studied population contains genetically different subsets. Significant association might be 
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due to the genetic difference between the case and control groups, which is unrelated to a 
given trait. In family-based analysis this is not an issue since the studied individuals share 
their genetic background, and in the GWAS studies it is possible to better control for the 
substructure by utilizing the genetic profiles of all the GWAS variants. 
Type 1 error is unfortunately a common cause of positive findings. It arises from the fact 
that the more tests that are performed, the more positive findings that are seen by chance. 
Bonferroni correction and methods taking into account the LD structure of the genome are 
used to correct for multiple testing (Nyholt 2004; Li et al. 2005). To exclude the possibility of 
type 1 error, adequately stringent limit for p-value significance and replication of findings in 
independent study cohorts are needed. Many of the earlier suggestive candidate gene 
associations have not been followed-up in the recent GWAS projects leaving the significance 
of the many earlier findings still unconvincing. The lack of replication in the follow-up 
cohort may indicate false positive initial association, but might also be due to a limited size 
of the replication cohort not having enough statistical power to detect an association with a 
small effect size.  
Differences in the phenotype definition may also be a cause for a seeming lack of replication 
(Kerkhof et al. 2011b). Very diverse diagnostic criteria have been used in different cohorts, 
which may have potentially enriched for specific subtypes of OA. However, in last few 
years there has also been successful attempts to harmonize the phenotype designation 
between cohorts (Evangelou et al. 2011). Further, the clinically used diagnostic criteria for 
OA are not always the optimal phenotypes in genetic studies. The clinical diagnosis has 
usually evolved historically on the basis of symptoms rather than the etiology of the disease 
(Plomin et al. 2009). Pain and disability caused by OA are likely affected by even a greater 
variety of genetic and environmental factors than the radiological findings of the joints, 
although they are naturally significant determinants in patient care. 
According to current understanding OA is a multi-factorial disease, and several genetic and 
environmental factors are expected to affect the susceptibility. Although a few genetic 
predisposing variants have been identified, most of the disease heritability remains unsolved. 
It has been suggested that OA is a polygenic disease with hundreds or even thousands of 
predisposing variants, each having very small effect on the disease susceptibility (Evangelou et 
al. 2011). The challenge of missing heritability has been brought up in search for genes for 
other complex diseases, where significantly larger international collaborative efforts have 
already been made, and tens of confirmed and well-replicated disease variants have been 
identified (International Multiple Sclerosis Genetics Consortium and Wellcome Trust Case 
Control Consortium 2, 2011; De Jager et al. 2009; Lango Allen et al. 2010). In such cases GWAS 
conducted by large consortia have been able to identify disease variants that explain 
approximately 10-20% of the heritable component. Although recent international collaborative 
efforts have identified a few confirmed variants for OA, significantly larger efforts are needed 
to tackle the yet unidentified OA predisposing variants.   
The methods in molecular genetics are developing rapidly, making it soon possible to 
sequence the entire human genome in a very reasonable time and cost, opening novel 
opportunities for genetic studies. Today we have plenty of suggestive evidence of the genes 
possibly involved in the etiology of OA, but what do we know for sure? We have rare 
mutations or variants in familial forms of OA, and a handful of confirmed genetic 
associations of common variants to continue in future studies on their biological function 
and role in the disease pathology. Significantly larger study cohorts with accurately defined 
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phenotypes, as well as studies on transcriptomics, proteomics, and lipidomics are needed 
for complete understanding of the disease.  
8. List of abbreviations 
Osteoarthritis: OA; linkage disequilibrium: LD; logarithm of odds: LOD; Genome-wide 
association analysis: GWAS; single nucleotide polymorphism: SNP; genome-wide linkage: 
GWL; distal interphalangeal: DIP; generalized OA: GOA; osteophyte: OST; proximal 
interphalangeal: PIP; joint space narrowing JSN; Kellgren Lawrence score KL; 
carpometacarpal CMC1; thumb interphalangeal: TIP, thumb IP; matrilin: MATN3; 
interphalangeal: IP; neuropilin 2: NRP2; isocitrate dehydrogenase 1 (NADP+) soluble: IDH1; 
frizzled-related protein: FRZB; interleukin 1 receptor 1: IL1R1; transcription factor AP-2 beta 
(activating enhancer binding protein 2 beta): TFAP2B; body mass index: BMI; Aggrecan: 
AGC1, ACAN: Aspirin: ASPN; collagen, type II, alpha 1: COL2A1; estrogen receptor 1: 
ESR1; growth differentiation factor 5: GDF5; odds ratio: OR; confidence interval: CI; insulin-
like growth factor 1: IGF-1; interleukin 1 beta: IL1B; matrilin 3: MATN3; acidic (leucine-rich) 
nuclear phosphoprotein 32 family, member A: ANP32A; SMAD family member 3: SMAD3; 
deiodinase, iodothyronine, type II: DIO2; deiodinase, iodothyronine, type III: DIO3; vitamin 
D (1,25- dihydroxyvitamin D3) receptor: VDR; multiple epiphyseal dysplasia: MED; 
arginine: Arg; cysteine: Cys; bone morphogenetic protein: BMP; SMAD specific E3 ubiquitin 
protein ligase 2: Smurf2; Wingless: Wnt; Interleukin: 1 IL-1; tumor necrosis factor ǂ: TNF-ǂ; 
c-Jun N-terminal kinase: JNK; p38 mitogen-activated protein kinase: p38 MAPK; nuclear 
factor kappa B: NF-κB; interleukin 1 receptor antagonist IL1RN; interleukin 6: IL-6; 
interleukin 4 receptor: IL4R; messenger RNA: mRNA; extracellular matrix: ECM; ADAM 
metallopeptidase with thrombospondin type 1 motif, 4: ADAMTS4; ADAM 
metallopeptidase with thrombospondin type 1 motif, 5: ADAMTS5; small interfering: 
siRNA; matrix metalloproteinase: MMP; interleukin 1 beta: IL-1ǃ; estrogen receptor 2: ESR2; 
total joint replacement: TJR; calmodulin 1: CALM1; leucine-rich repeats and calponin 
homology (CH) domain containing 1: LRCH1; prostaglandin-endoperoxide synthase 2: 
PTGS2; phospholipase A2, group IVA (cytosolic, calcium-dependent): PLA2G4A; collagen, 
type VI, alpha 4 pseudogene 1: DVWA, COL6A4P1; butyrophilin-like 2 (MHC class II 
associated): BTNL2; major histocompatibility complex, class II, DR alpha: HLA-DRA; major 
histocompatibility complex, class II, DR beta 5: HLA-DRB5; major histocompatibility 
complex, class II, DR beta 1: HLA-DRB1; major histocompatibility complex, class II, DQ 
alpha 1: HLA-DQA1; major histocompatibility complex, class II, DQ beta 1: HLA-DQB1; 
RNA binding protein, fox-1 homolog (C. elegans) 1: A2BP1, RBFOX1; component of 
oligomeric golgi complex 5: COG5; tribbles homolog 1 (Drosophila): TRIB1; interleukin 1 
receptor accessory protein: IL1RAP; E74-like factor 3 (ets domain transcription factor, 
epithelial-specific ): ELF3; collagen, type XI, alpha 1: COL11A1; minor allele frequency: 
MAF; Utah residents with Northern and Western European ancestry from the CEPH 
collection: CEU; dihydrouridine synthase 4-like (S. cerevisiae): DUS4L; component of 
oligomeric golgi complex 5: COG5; G protein-coupled receptor 22: GPR22; B-cell receptor-
associated protein 29: BCAP29; protein kinase, cAMP-dependent, regulatory, type II, beta: 
PRKAR2B; PBRM1 polybromo 1: HPB1, PBRM1; calpain 7: CAPN7; ubiquinol-cytochrome c 
reductase complex chaperone: UQCC; centrosomal protein 250kDa: CEP250; hyaluronan: 
HA; cartilage oligomeric matrix protein: COMP; collagen IIA N-propeptide: PIIANP; high 
sensitive C-reactive protein: hs-CRP; glycated serum protein: GSP. 
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